Insilico Medicine vs Turing
Relationship
MMAI Gym and Turing Frontier AI do comparable work on model training; both also serve buyers who need to train or fine-tune a model; similar scale (private); ships agent platform and data service rather than the same layer.
Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.
3 of 8 capabilities — Shares agent orchestration, evaluation and observability and model training.
Ludbee capability tags · from the product recordsDifferent layer — Turing ships agent platform and data service, not the same layer.
Ludbee product recordsAligned comparison
Capability overlap
Shared · 3
Not verified for Turing · 5
Recorded for Insilico Medicine. Turing’s product records say nothing either way — a missing record is not a missing capability.
Not verified for Insilico Medicine · 3
Recorded for Turing. Insilico Medicine’s product records say nothing either way — a missing record is not a missing capability.
Products, side by side
Algorithmic pairing — assembled from recorded fields, not hand-checked
Insilico Medicine
No shared stack layer with the other side.
Turing
No shared stack layer with the other side.
No counterpart
Insilico Medicine sells these in a stack layer with no product recorded for Turing yet — nothing on the other side to compare them against.
Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
Turing sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.
Agent platform
An AI control plane that deploys, manages and scales enterprise AI agents across any model and any cloud, with governance and IP and sovereignty controls.
Data service
A catalogue of pre-built, PhD-authored and expert-verified datasets — including CyberStrike, CompanyBench, EKWBench, SciCode and HLE++ — licensed to AI labs for reinforcement learning, benchmarking and model evaluation.
Iterable UI and non-UI reinforcement-learning environments — including MCP server, computer-use and terminal environments — in which AI agents can be trained and evaluated on long-horizon workflows.
The training material a frontier lab runs on, sold as a service: 300+ reinforcement-learning environments, over a million curated tasks, and named benchmarks including CompanyBench, CyberStrike and Terminal-Bench 3.0, across software engineering, enterprise knowledge work and STEM.